Startups
See how ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor) compares to other medications and talk to your doctor about the right move for you. See Important Safety Information and full Prescribing Information, including Medication Guide with Important Warning for TRIKAFTA and ALYFTREK.
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 9, 2023 | Health | $200,000-a-year cystic fibrosis medication deemed “affordable” by Colorado review board because of coupons | Colorado’s new prescription drug review board decided in a first-in-the-nation vote that a medication costing more than $200,000 a year doesn’t qualify as “unaffordable,” based on the drug’s benefits to patients and the availability of coup... |
Reviews 0
FAQ about Your Next Move
What has the press written about Your Next Move?
Parsers VC has collected 2 articles mentioning Your Next Move, among them “Health | $200,000-a-year cystic fibrosis medication deemed “affordable” by Colorado review board because of coupons” (Dec 9, 2023).
Is Your Next Move still active?
Yes, Your Next Move is active; its latest activity on Parsers VC dates from Mar 31, 2025.